Analysis of the 42,000 public comments submitted to the Drug Enforcement Administration (DEA) regarding cannabis rescheduling shows ‘overwhelming support’ for reform.
New analysis from cannabis data platform Headset shows an ‘unprecedented’ level of engagement from the American public, with the response to cannabis rescheduling breaking the previous engagement record of 38,000 comments, submitted in 2020 regarding controversial telemedicine rules, comfortably.
More importantly, the vast majority of responses submitted were in favour of the proposals to move cannabis from a Schedule I substance to Schedule III, with many suggesting that the DEA should go even further and deschedule cannabis altogether.
According to Headset’s analysis, 92.45% of comments were in favour of changing cannabis’s schedule in the Controlled Substances Act (CSA), meaning just 7.55% of respondents were against the change.
Furthermore, the majority of respondents (61.7%) called for cannabis to be descheduled completely, while 38.3% supported rescheduling to a less restrictive category.
“This overwhelming show of public support, equivalent to the unanimous voice of an entire state capital, sends a powerful message to policymakers. It suggests that not only is there broad backing for the proposed rescheduling, but there’s also a significant push for even more comprehensive reform,” the company stated.
A number of key themes were also revealed during Headset’s analysis. One ‘notable phenomenon’ was the appearance of distinct spikes in comments opposing rescheduling that coincided with coordinated efforts by opposition groups.
One significant instance occurred on July 15, when Smart Approaches to Marijuana (SAM), an organization against cannabis legalization, issued a call to action to its supporters. SAM provided a form letter and urged supporters to submit comments, resulting in a noticeable surge in opposition submissions on that day.
These findings underscore the impact of organized advocacy groups on public comment periods and highlight the importance of examining both the content and timing of comments to fully understand public sentiment.
Despite the overwhelming public support for the rescheduling, a number of significant challenges remain, including the potential waning of political support for the move should no progress be made before November’s presidential election.
Over 90% of Cannabis Rescheduling Comments Are in Favour of the Move, With the Majority Calling for Further Reform
Analysis of the 42,000 public comments submitted to the Drug Enforcement Administration (DEA) regarding cannabis rescheduling shows ‘overwhelming support’ for reform.
New analysis from cannabis data platform Headset shows an ‘unprecedented’ level of engagement from the American public, with the response to cannabis rescheduling breaking the previous engagement record of 38,000 comments, submitted in 2020 regarding controversial telemedicine rules, comfortably.
More importantly, the vast majority of responses submitted were in favour of the proposals to move cannabis from a Schedule I substance to Schedule III, with many suggesting that the DEA should go even further and deschedule cannabis altogether.
According to Headset’s analysis, 92.45% of comments were in favour of changing cannabis’s schedule in the Controlled Substances Act (CSA), meaning just 7.55% of respondents were against the change.
Furthermore, the majority of respondents (61.7%) called for cannabis to be descheduled completely, while 38.3% supported rescheduling to a less restrictive category.
“This overwhelming show of public support, equivalent to the unanimous voice of an entire state capital, sends a powerful message to policymakers. It suggests that not only is there broad backing for the proposed rescheduling, but there’s also a significant push for even more comprehensive reform,” the company stated.
A number of key themes were also revealed during Headset’s analysis. One ‘notable phenomenon’ was the appearance of distinct spikes in comments opposing rescheduling that coincided with coordinated efforts by opposition groups.
One significant instance occurred on July 15, when Smart Approaches to Marijuana (SAM), an organization against cannabis legalization, issued a call to action to its supporters. SAM provided a form letter and urged supporters to submit comments, resulting in a noticeable surge in opposition submissions on that day.
These findings underscore the impact of organized advocacy groups on public comment periods and highlight the importance of examining both the content and timing of comments to fully understand public sentiment.
Despite the overwhelming public support for the rescheduling, a number of significant challenges remain, including the potential waning of political support for the move should no progress be made before November’s presidential election.
Relm Risk Briefing: Cannabis 2026
The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.
What's covered
Key insights
Download Relm Risk Briefing: Cannabis 2026
Get your free copy of the comprehensive risk analysis report.
Cannabis Rescheduling Enters Next Phase as Comment Period Closes
Next PostCanadian Cannabis Council Pushes Back on Israel’s Threats to Tax Imports
Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, they have researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Related Posts
Related Posts
Spanish Pharmacists Appeal Hospital-Only Cannabis Rule as Key Regulatory Deadline Passes Unmet
Spain represents one of the most exciting incoming additions to the European medical cannabis market this year, as one of...
Inside the Medical Cannabis Police Guidance: Cancards, Driving, and What Patients Need to Know
Earlier this week, the first official guidance on medical cannabis for police officers in England and Wales was made public. Its...
UK Police Finally Get Official Medical Cannabis Guidance More Than 7 Years After Legalisation
Germany’s Medical Cannabis Bill Faces Critical Test as Experts Warn of ‘Unenforceable’ Framework
Industry Leaders React to Historic Cannabis Rescheduling
Cannabis Rescheduling is Here: Trump Signs Executive Order to Move Cannabis to Schedule III
Cannabis Europa Paris
Europe’s leading cannabis policy, business and investment conference — bringing senior decision-makers together in Paris.
CONNECT
Related Posts
Related Posts
France Extends Medical Cannabis Access Again as Full Access Bill Remains Stuck in Limbo
Thousands of French medical cannabis patients will continue to receive their treatment for the foreseeable future, as the highly anticipated...
Relm and Prohibition Partners Launch Cannabis Risk Briefing for Emerging and High-Growth Industries
Relm Insurance (Relm), the leading insurer focused on emerging industries, today released its Risk Briefing: Cannabis 2026, an inaugural global...
The Battle for Germany’s Medical Cannabis Market: Who’s Fighting for What
Today, (Wednesday, January 14), a public hearing will bring together 22 hand-picked experts for a debate on the future country's...
Republican Lawmakers Openly Defy Trump on Cannabis Rescheduling
As the excitement around President Donald Trump's executive order to push forward with cannabis rescheduling has faded, the bill is...
Spanish Pharmacists Appeal Hospital-Only Cannabis Rule as Key Regulatory Deadline Passes Unmet
Spain represents one of the most exciting incoming additions to the European medical cannabis market this year, as one of...
Recent Posts
Related Posts
Republican Lawmakers Openly Defy Trump on Cannabis Rescheduling
As the excitement around President Donald Trump's executive order to push forward with cannabis rescheduling has faded, the bill is...
Drug War 2.0 Puts International Cannabis Reform at Risk
The United States is intensifying its controversial overseas ‘war on drugs’ even as a prolonged government shutdown paralyses domestic policy,...
Manufactured Optimism: Why Trump Can’t ‘Just Wave a Magic Wand’ and Reschedule Cannabis
There is a frustrating misimpression circulating in the cannabis community regarding rescheduling. Many headlines state that Trump is considering finishing...
Pressure Builds on Trump Administration to take Definitive Stance on Cannabis Rescheduling
Pressure is building on the Trump administration from parties on both sides of the aisle to take a definitive stance...
Cannabis Stocks Hit Highest Point This Year on Trump Rescheduling Hopes
Cannabis stocks across North America have skyrocketed to their highest point so far this year, despite a lukewarm promise from...
Subscribe to our mailing list to receives daily updates!
We won’t spam you
Categories
Browse by Tags